Smith And Sapphire Bio-Tech Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1995.
1995 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Smith And Sapphire Bio-Tech Limited

Smith And Sapphire Bio-Tech Limited, a active public limited company, was established on 03 February 1995 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74899DL1995PLC065063. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹4.00 Cr.

It upholds a active non-compliant status. Its leadership includes Rohit Choudhary Kumar (Director), Mahmud Kazi (Director), Dilip Kumar Pandey (Director). Past directors included Nishan Gujra Singh, Ruchi Mittal, Rohit Choudhary Kumar. It holds ₹1.84 Cr open charges and no settled loans. Its latest AGM occurred on 28 September 2011, with the balance sheet filed on 31 March 2011. It is based at C-128/1 First Floor Mohammadpur, Bhikaji Cama Place, New Delhi, Delhi, 110066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1995PLC065063

  • Registration Number

    065063

  • Incorporation Date

    03 February 1995

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹4.00 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 31 Year, 18 Days
  • Last Filing with ROC 31 Mar 2011
  • Open Charges ₹ 1.84 Cr
Company report

Smith And Sapphire Bio-Tech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Smith And Sapphire Bio-Tech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Smith And Sapphire Bio-Tech Limited?
Current Directors
Name Designation Appointment Date Status
Rohit Choudhary Kumar Director 28 May 2016 Current
Mahmud Kazi Director 28 May 2016 Current
Dilip Kumar Pandey Director 28 May 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Jun 2014 Past
Pramod Abcsdd Director 20 Oct 2011 Past
Pramod Abcsdd Director 28 May 2016 Past
Pramod Abcsdd Director 28 Jun 2014 Past
Pramod Abcsdd Additional Director 01 Jun 2012 Past
Pramod Abcsdd Director 28 May 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Smith And Sapphire Bio-Tech.

Enhance accessibility to Smith And Sapphire Bio-Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Smith And Sapphire Bio-Tech revenue growth over time
Smith And Sapphire Bio-Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Smith And Sapphire Bio-Tech?

Unlock access to Smith And Sapphire Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹18,435,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Oriental Bank Of Commerce : 1.04 Cr
  • Punjab National Bank : 0.80 Cr
Latest Charge Details
Date Lender Amount Status
12 Aug 2013 Oriental Bank Of Commerce ₹1.44 M Open
12 Dec 2012 Oriental Bank Of Commerce ₹9.00 M Open
24 Oct 2009 Punjab National Bank ₹8.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Smith And Sapphire Bio-Tech?

Unlock and access historical data on people associated with Smith And Sapphire Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smith And Sapphire Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smith And Sapphire Bio-Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Smith And Sapphire Bio-Tech
Recent Activity within the Organization
  • Director Appointment

    Progress on Rohit Choudhary Kumar was appointed as a Director was appointed as a Director on 28 May 2016 & has been associated with this company since 9 years 8 months . was documented.

  • Director Appointment

    Progress on Mahmud Kazi was appointed as a Director was appointed as a Director on 28 May 2016 & has been associated with this company since 9 years 8 months . was documented.

  • Director Appointment

    The activity Dilip Kumar Pandey was appointed as a Director was appointed as a Director on 28 May 2016 & has been associated with this company since 9 years 8 months . was completed.

  • Charges

    Progress on A charge with Oriental Bank Of Commerce amounted to Rs. 0.14 Cr with Charge ID 10446008 was registered on 12 Aug 2013. was documented.

  • Charges

    The activity A charge with Oriental Bank Of Commerce amounted to Rs. 0.90 Cr with Charge ID 10496310 was registered on 12 Dec 2012. was completed.

  • Annual General Meeting

    The activity Smith And Sapphire Bio-Tech Limited last Annual general meeting of members was held on 28 Sep 2011 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Smith And Sapphire Bio-Tech Limited?

The CIN of Smith And Sapphire Bio-Tech Limited is U74899DL1995PLC065063.

Where is Smith And Sapphire Bio-Tech Limited headquartered?

Smith And Sapphire Bio-Tech Limited is headquartered at C-128/1 First Floor Mohammadpur, Bhikaji Cama Place, New Delhi, Delhi, 110066.

When was Smith And Sapphire Bio-Tech Limited incorporated?

Smith And Sapphire Bio-Tech Limited was incorporated on 03 February 1995.

Who are the current directors of Smith And Sapphire Bio-Tech Limited?

The current directors of Smith And Sapphire Bio-Tech Limited are

What is the primary industry of Smith And Sapphire Bio-Tech Limited?

The primary industry of Smith And Sapphire Bio-Tech Limited is Pharma.

Is Smith And Sapphire Bio-Tech Limited a listed company?

Smith And Sapphire Bio-Tech Limited is unlisted.

What is the capital structure of Smith And Sapphire Bio-Tech Limited?

The authorized capital of Smith And Sapphire Bio-Tech Limited is ₹4.00 Cr, and the paid-up capital is ₹4.00 Cr.

What is the compliance status of Smith And Sapphire Bio-Tech Limited?

The compliance status of Smith And Sapphire Bio-Tech Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available